Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07246200 · ClinicalTrials.gov registry record · NA
TED Stocking vs. Reparel Garment After Hip Replacement
A NA study of Osteoarthritis (OA) of the Hip, sponsored by Reparel.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07246200: Active NA study of Osteoarthritis (OA) of the Hip, sponsored by Reparel.
NCT07246200 is a NA study of Osteoarthritis (OA) of the Hip that is active but no longer recruiting, run by Reparel. The registered enrollment target is 50 participants, below the 3,413-participant average among 3 other Osteoarthritis (OA) of the Hip trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07246200, a NA study of Osteoarthritis (OA) of the Hip, is active but no longer recruiting, sponsored by Reparel.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized, prospective study compares the effectiveness of a novel bioactive garment (Reparel Leg Sleeve) versus standard TED compression stockings in reducing postoperative leg swelling, pain, and deep vein thrombosis (DVT) rates following total hip arthroplasty. The study aims to determine whether the bioactive garment improves patient comfort and recovery outcomes compared to traditional stockings.
Primary Outcome
Pain will be measured using the Visual Analog Scale (VAS), a standard 0-10 numeric rating scale. Patients will report pain levels during routine postoperative follow-up visits or via validated questionnaires.
Conditions Studied
Interventions
- DEVICE Reparel Bioactive Sleeve
- DEVICE TED Stocking
Study Locations (1)
California
- Institute for Joint Restoration - Fremont
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT07246200 still lists
NCT07246200 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 3,413-participant average among 3 other Osteoarthritis (OA) of the Hip trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Osteoarthritis (OA) of the Hip appearing as the primary indexed condition, and to 2 interventions - of which Reparel Bioactive Sleeve is the first listed.
NCT07246200 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07246200 about?
NCT07246200 is a clinical study titled "TED Stocking vs. Reparel Garment After Hip Replacement". This randomized, prospective study compares the effectiveness of a novel bioactive garment (Reparel Leg Sleeve) versus standard TED compression stockings in reducing postoperative leg swelling, pain, and deep vein thrombosis (DVT) rates following total hip arthroplasty. The study aims to determine w...
What is the current status of trial NCT07246200?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-01-01. Estimated completion is 2026-12.
What conditions does trial NCT07246200 study?
This clinical trial studies the following conditions: Osteoarthritis (OA) of the Hip.
What interventions are being tested in trial NCT07246200?
The interventions under investigation include: Reparel Bioactive Sleeve (DEVICE), TED Stocking (DEVICE).
Who is sponsoring clinical trial NCT07246200?
This trial is sponsored by Reparel, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07246200 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis (OA) of the Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI